Jazz Pharmaceuticals, Inc.

Teladoc Health to Acquire InTouch Health
Vivante Health Snags DebraAnn Braun as Chief Technology Officer
Dr. Jason Hallock Joins SOC Telemed as Chief Medical Officer
Change Healthcare Unveils API & Services Connection, a Marketplace to Accelerate Innovation in Healthcare
Gemelli Hospital on Track to Become More Digitized for Better Patient Management

Alkermes Initiates Rolling Submission of ALKS 5461 New Drug Application for Major Depressive Disorder
Alkermes Announces Positive Preliminary Topline Results From Phase 3 Antipsychotic Efficacy Study of ALKS 3831 for Treatment of Schizophrenia
Alkermes Announces Initiation of Study 217 for ALKS 5461 for Treatment of Major Depressive Disorder
Alkermes Announces Initiation of Phase 3 Study of ALKS 3831 in Young Adult Patients
FDA Approves Two-Month ARISTADA® for Treatment of Schizophrenia